Sponsor pipeline

Aimei Vacin BioPharm (Zhejiang) Co., Ltd. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1		1
Phase 3		1

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06044077	A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal…	Pneumococcal Disease	Recruiting	2023-09-21
Phase 1
NCT07598890	Phase I Clinical Trial of Adsorbed Tetanus Vaccine	Tetanus	Active, Not Recruiting	2026-09-22

Get alerts when Aimei Vacin BioPharm (Zhejiang) Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.